Vicente Anido, Jr.
2018
In 2018, Vicente Anido, Jr. earned a total compensation of $6.8M as Chief Executive Officer and Chairman of the Board at Aerie Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $409,500 |
|---|---|
| Option Awards | $4,254,360 |
| Salary | $750,000 |
| Stock Awards | $1,360,866 |
| Total | $6,774,726 |
Anido received $4.3M in option awards, accounting for 63% of the total pay in 2018.
Anido also received $409.5K in non-equity incentive plan, $750K in salary and $1.4M in stock awards.
Rankings
In 2018, Vicente Anido, Jr.'s compensation ranked 1,314th out of 14,244 executives tracked by ExecPay. In other words, Anido earned more than 90.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,314 out of 14,244 | 91st |
Division Manufacturing | 457 out of 5,765 | 92nd |
Major group Chemicals And Allied Products | 141 out of 2,128 | 93rd |
Industry group Drugs | 110 out of 1,817 | 94th |
Industry Biological Products, Except Diagnostic Substances | 27 out of 339 | 92nd |
Source: SEC filing on April 10, 2019.
Anido's colleagues
We found four more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2018.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019